STOCK TITAN

Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, May 2, 2023 at 8:00 a.m. ET to review first quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.

Investor Contact

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.com



Media Contact

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

Sage Therapeutics, Inc.

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

722.18M
47.55M
12.56%
95.55%
14.31%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
CAMBRIDGE